News Releases

This section contains information and press releases about Boston Scientific. Press releases are listed in chronological order and archived by year. Information should be considered accurate as of the date prepared. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Boston Scientific is not obligated to update the press releases and information contained in this section of the website.

Click here to access archived Guidant press releases.

Archives: Search / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005 / 2004

2016 Archives

	Dec 30, 2016 Boston Scientific To Participate In 35th Annual J.P. Morgan Healthcare Conference Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 35th Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2017 in San Francisco. Mike Mahoney, chairman and... More
	Dec 13, 2016 Boston Scientific Closes Acquisition of Advanced Biological Tissue Capabilities and Acquires Common Shares of Neovasc, Inc. Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of certain manufacturing assets and capabilities of the Neovasc, Inc., (NASDAQ: NVCN) (TSX: NVC) advanced... More
	Dec 5, 2016 Boston Scientific Earns Perfect Score on Human Rights Campaign's Corporate Equality Index Third consecutive “Best Places to Work for LGBT Equality” award MARLBOROUGH, Mass., December 5, 2016 — Boston Scientific (NYSE: BSX) has been recognized for the third consecutive year as a “Best Place to Work” by the Human Rights Campaign Foundation. The... More
	Dec 2, 2016 Boston Scientific Announces Agreement to Acquire Neovasc Advanced Biological Tissue Capabilities ‒ $75M transaction enhances manufacturing expertise in structural heart Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire certain manufacturing assets and capabilities of the Neovasc, Inc., (NASDAQ: NVCN) (TSX: NVC) advanced... More
	Nov 23, 2016 Boston Scientific To Participate In Citi 2016 Global Healthcare Conference Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Citi 2016 Global Healthcare Conference on December 7 in New York City. Dan Brennan, executive vice president & chief... More
	Nov 22, 2016 Boston Scientific Closes EndoChoice Acquisition Acquisition Expands Endoscopy Portfolio Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of EndoChoice Holdings, Inc. (NYSE: GI). With the completion of the acquisition, EndoChoice will become part... More
	Nov 21, 2016 Boston Scientific Receives 2016 Shingo Prize for Operational Excellence Boston Scientific today announced that its Cork, Ireland manufacturing facility has received the 2016 Shingo Prize for Excellence in Manufacturing from the Shingo Institute, part of the Jon M.... More
	Nov 16, 2016 Boston Scientific To Participate In Piper Jaffray 2016 Healthcare Conference Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 28th Annual Piper Jaffray Healthcare Conference on November 29 in New York City. Jeff Mirviss, senior vice president &... More
	Nov 16, 2016 Boston Scientific Announces Positive Results Of HeartLogic™ Heart Failure Diagnostic Service Late-Breaking Trial Data Presented at AHA Scientific Sessions Demonstrate Success of Alert to Predict Worsening Heart Failure Boston Scientific (NYSE: BSX) today announced results from the first clinical trial evaluating the performance of the HeartLogic™ Heart Failure Diagnostic Service to predict impending heart... More
	Nov 15, 2016 Boston Scientific Acquires Resectr™ Tissue Resection Device from Distal Access, LLC Acquisition Advances Treatment Options for Women with Uterine Polyps Boston Scientific (NYSE: BSX) has acquired the gynecology and urology portfolio of Distal Access, LLC, a Salt Lake City based company that designs minimally invasive medical devices. The portfolio... More
	Nov 8, 2016 Boston Scientific Launches the Dakota™ Nitinol Stone Retrieval Device with Opensure™ Handle Kidney Stone Retrieval Device Enables Physicians to Release and Capture Kidney Stones of Multiple Sizes MARLBOROUGH, Mass., (Nov. 8, 2016) – Boston Scientific Corporation (NYSE: BSX) today announced the U.S. and European launch of the Dakota™ Nitinol Stone Retrieval Device with OpenSure™... More
	Nov 4, 2016 Boston Scientific Announces Extension of the Cash Tender Offer for All Shares of EndoChoice Boston Scientific Corporation (NYSE: BSX) today announced that its wholly owned merger subsidiary, Falcon Merger Corp., has extended its previously announced tender offer for all shares of... More
	Nov 3, 2016 Boston Scientific Announces Acquisition Of The LumenR™ Tissue Retractor System Technology to Improve Management of Gastrointestinal Diseases Boston Scientific (NYSE: BSX) today announced the acquisition of the LumenR™ Tissue Retractor System from LumenR LLC, a privately held Newark, California based company. The LumenR Tissue... More
	Nov 2, 2016 Boston Scientific Announces Initial U.S. Commercial Performance Of The WATCHMAN™ Left Atrial Appendage Closure Device Late-Breaking Trial Data Presented at TCT Scientific Sessions and Simultaneously Published in the Journal of the American College of Cardiology Boston Scientific (NYSE: BSX) announced initial U.S. commercial performance results of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device today during a late-breaking clinical trial... More
	Nov 1, 2016 Primary Endpoint from Study of Drug Eluting Coronary Stent in Underserved Patient Populations Presented at TCT 2016 The PLATINUM Diversity Study Provides Much Needed Data about Women and Minority Patients, Who are Under-represented in Cardiology Clinical Trials As part of the commitment to support health equity for all patients, Boston Scientific Corporation (NYSE: BSX) sponsored the PLATINUM Diversity study to evaluate the clinical outcomes of the... More
	Oct 27, 2016 Boston Scientific To Participate In Stifel 2016 Healthcare Conference Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Stifel 2016 Healthcare Conference on November 15 in New York City. Dan Brennan, executive vice president & chief... More
	Oct 26, 2016 Boston Scientific Announces Results For Third Quarter 2016 Boston Scientific Corporation (NYSE: BSX) generated sales of $2.105 billion during the third quarter ended September 30, 2016, compared to the company's guidance range for the quarter of $2.035 to... More
	Oct 25, 2016 Boston Scientific To Participate In 25th Annual Credit Suisse Healthcare Conference Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 25th Annual Credit Suisse Healthcare Conference on November 7, in Scottsdale, Arizona. Joe Fitzgerald, executive vice... More
	Oct 24, 2016 Boston Scientific Announces Scheduled Presentations at Transcatheter Cardiovascular Therapeutics 2016 Boston Scientific (NYSE: BSX) today announced key data which will be presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular... More
	Oct 17, 2016 Boston Scientific Launches Resolution 360™ Clip Launch of Hemostasis Clip Advances Innovation within the Field of Endoscopy Boston Scientific Corporation (NYSE: BSX) today announced the launch of the Resolution 360™ Clip, a novel technology designed to improve hemostatic clipping by providing physicians controlled... More
	Oct 13, 2016 Boston Scientific Competition Seeks Concepts Applying Analytics to Big Data for Better Patient Outcomes Second Boston Scientific Connected Patient Challenge focuses on digital health Marlborough, Mass. October 13, 2016) -- Boston Scientific Corporation (NYSE: BSX) today announced a worldwide call for submissions to the second annual Boston Scientific Connected Patient... More
	Oct 10, 2016 Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer Boston Scientific Corporation (NYSE: BSX) announced today that Professor Ian Meredith AM will join the company as executive vice president and global chief medical officer in January 2017. In his... More
	Oct 7, 2016 Boston Scientific Commences Cash Tender Offer For All Shares Of EndoChoice For $8.00 Per Share In Cash Boston Scientific Corporation (NYSE: BSX) today announced that its wholly owned merger subsidiary, Falcon Merger Corp., has launched its previously announced tender offer for all shares of... More
	Oct 3, 2016 Boston Scientific to Webcast Conference Call Discussing Third Quarter 2016 Financial Results on October 26 Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the third quarter ended September 30, 2016 on Wednesday, October... More
	Sep 27, 2016 Boston Scientific to Acquire EndoChoice Acquisition Will Expand Endoscopy Gastroenterology Portfolio Boston Scientific (NYSE: BSX) and EndoChoice Holdings, Inc. (NYSE: GI) today announced the companies have entered into a definitive agreement under which Boston Scientific has agreed to acquire... More
1-25 26-50 51-68